US Stock MarketDetailed Quotes

GLMD Galmed Pharmaceuticals

Watchlist
  • 2.8000
  • -0.1600-5.41%
Close Nov 21 16:00 ET
  • 2.8000
  • 0.00000.00%
Post 20:01 ET
4.22MMarket Cap-667P/E (TTM)

Galmed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Galmed Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Galmed Pharmaceuticals Earnings Reports

  • Galmed Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 14 17:33 ET

  • Galmed Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 14 16:13 ET

  • Galmed Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 30 16:18 ET

  • Galmed Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 28 16:34 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data